English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
TCCIA: A comprehensive resource for exploring CircRNA in cancer immunotherapy Journal article
Wang, Shixiang, Xiong, Yi, Zhang, Yihao, Wang, Haitao, Chen, Minjun, Li, Jianfeng, Luo, Peng, Luo, Yung Hung, Hecht, Markus, Frey, Benjamin, Gaipl, Udo, Li, Xuejun, Zhao, Qi, Ma, Hu, Zhou, Jian Guo. TCCIA: A comprehensive resource for exploring CircRNA in cancer immunotherapy[J]. Journal for ImmunoTherapy of Cancer, 2024, 12(1), e008040.
Authors:  Wang, Shixiang;  Xiong, Yi;  Zhang, Yihao;  Wang, Haitao;  Chen, Minjun; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:10.3/11.6 | Submit date：2024/02/22
Biomarkers, Tumor  Genetic Markers  Immunotherapy  Tumor Biomarkers  
Editorial: New progress in cancer biomarkers and therapy Other
2024-01-01
Authors:  Sun, Guohui;  He, Chengwei;  Wang, Jianhua
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2024/05/16
Bioinformatics  Biomarkers  Cancer  Tumor Microenvironment  Tumor Prognosis  Tumor Resistance  Tumor Therapy  
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation Journal article
Zhou,Jing Bo, Tang,Dongyang, He,Lin, Lin,Shiqi, Lei,Josh Haipeng, Sun,Heng, Xu,Xiaoling, Deng,Chu Xia. Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation[J]. Pharmacological Research, 2023, 194, 106830.
Authors:  Zhou,Jing Bo;  Tang,Dongyang;  He,Lin;  Lin,Shiqi;  Lei,Josh Haipeng; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:9.1/9.0 | Submit date：2023/08/03
Bortezomib (Pubchem Cid: 387447)  Cepharanthine (Pubchem Cid: 10206)  Docetaxel (Taxotere) (Pubchem Cid: 11970251)  Drug Combination Therapy  Flunarizine Dihydrochloride (Pubchem Cid: 5282407)  Lapatinib Ditosylate (Pubchem Cid: 9941095)  Machine Learning  Pazopanib Hydrochloride (Pubchem Cid: 11525740)  Potential Combination Biomarkers  Tamoxifen Citrate (Pubchem Cid: 2733525)  Three-dimensional Tumor Slice Culture  Vatalanib (Pubchem Cid: 151194)  Vincristine (Pubchem Cid: 5978)  Xl-184 (Cabozantinib) (Pubchem Cid: 25102847)  
Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment Journal article
Bao, Qianqian, Huang, Qianqian, Chen, Yunna, Wang, Qiang, Sang, Ran, Wang, Lei, Xie, Ying, Chen, Weidong. Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment[J]. Frontiers in Molecular Biosciences, 2022, 8.
Authors:  Bao, Qianqian;  Huang, Qianqian;  Chen, Yunna;  Wang, Qiang;  Sang, Ran; et al.
Favorite | TC[WOS]:30 TC[Scopus]:36  IF:3.9/4.4 | Submit date：2023/01/30
Angiogenesis  Biomarkers  Extracellular Vesicles  Immune Cells  Resistance  Tumor Microenvironment